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We previously reported a synthetic Laponite crosslinked pNIPAM-co-DMAc (L-pNIPAM-co-DMAc)
hydrogel which promotes differentiation of mesenchymal stem cells (MSCs) to nucleus pulposus (NP)
cells without additional growth factors. The clinical success of this hydrogel is dependent on: integration
with surrounding tissue; the capacity to restore mechanical function; as well as supporting the viability
and differentiation of delivered MSCs. Bovine NP tissue explants were injected with media (control),
human MSCs (hMSCs) alone, acellular L-pNIPAM-co-DMAc hydrogel or hMSCs incorporated within the
L-pNIPAM-co-DMAc hydrogel and maintained at 5% O2 for 6 weeks. Viability of native NP cells and deliv-
ered MSCs was maintained. Furthermore hMSCs delivered via the L-pNIPAM-co-DMAc hydrogel differen-
tiated and produced NP matrix components: aggrecan, collagen type II and chondroitin sulphate, with
integration of the hydrogel with native NP tissue. In addition L-pNIPAM-co-DMAc hydrogel injected into
collagenase digested bovine discs filled micro and macro fissures, were maintained within the disc during
loading and restored IVD stiffness. The mechanical support of the L-pNIPAM-co-DMAc hydrogel, to
restore disc height, could provide immediate symptomatic pain relief, whilst the delivery of MSCs over
time regenerates the NP extracellular matrix; thus the L-pNIPAM-co-DMAc hydrogel could provide a
combined cellular and mechanical repair approach.
Statement of Significance
Low back pain (LBP) is associated with degeneration of the intervertebral disc (IVD). We have previously
described development of a jelly delivery system (hydrogel). This has the potential to deliver adult stem
cells to the centre of the IVD, known as the nucleus pulposus (NP). Here, we have demonstrated that adult
stem cells can be safely injected into the NP using small bore needles, reducing damage to the disc.
Following injection the hydrogel integrates with surrounding NP tissue, promotes differentiation of stem
cells towards disc cells and restores IVD mechanical function. The hydrogel could be used to restore
mechanical function to the IVD and deliver cells to promote regeneration of the disc as a minimally inva-
sive treatment for LBP.
 2017 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CCBY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Low back pain (LBP) is an increasingly prevalent clinical
condition that affects over 80% of the population at some point
during their lifetime [1]. The aetiology of chronic LBP is thought
to be multifactorial; however, degeneration of the intervertebral
disc (IVD) is regarded as a key attributing factor [2,3]. Morpholog-
ically the IVD can be divided into three distinct regional structures:
the cartilaginous endplates (CEP); the annulus fibrosus (AF) and
the central gelatinous nucleus pulposus (NP), rich in proteoglycans
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facilitates a range of spinal movement and dissipates energy dur-
ing motion [5].
Degeneration of the IVD is characterised by a number of pro-
gressive extracellular matrix (ECM) changes including altered
matrix synthesis and increased degradation of normal matrix com-
ponents [6], resulting in an overall reduction in the proteoglycan
content of the NP [7]. This is mediated by the catabolic phenotype
of degenerate NP cells [8,9] alongside decreased viability as well as
increased apoptosis [17] and senescence of remaining NP cells [10].
This results in reduced NP tissue hydration and an overall loss in
disc height [11], culminating in mechanical failure resulting in
abnormal stresses to surrounding spinal tissues and compression
of nerve routes [12]. Consequently, the restoration of disc height
is a key therapeutic target for the symptomatic relief of chronic
LBP.
New approaches in tissue engineering have led to the investiga-
tion of a variety of treatment options aimed at the restoration of
disc height using acellular implants [13–16], the use of regenera-
tive cells [17–20] or the combined delivery of regenerative cells
with supporting mechanical scaffolds [21,22]. Mesenchymal stem
cells (MSCs) have been highlighted as an attractive cell choice since
they have proliferative capacity, can be extracted from a variety of
adult tissues and have the capacity to differentiate into NP like
cells [19,20,23–25]. However, concerns remain regarding MSC
leakage [26], as well as a lack of control over differentiation follow-
ing injection [27], thus highlighting the potential need for cell car-
rier systems. The use of a combined approach is appealing, since it
is hypothesised that the mechanical support of the biomaterial
scaffold would provide immediate pain relief. Whilst, the delivery
of regenerative cells, would provide a long term, gradual regener-
ation of an ECM which biologically functions, akin to native NP tis-
sue. To date, a variety of biomaterial scaffolds have been
investigated for repair of the NP. However injectable scaffolds with
the potential to deliver cells, have not demonstrated the required
mechanical robustness [14]. Whilst those developed as acellular
NP replacement scaffolds have so far failed, due to poor integration
resulting in extrusion or expulsion of the implanted material
[14,28,29] or are unable to deliver regenerative cells to the IVD
[13–16]. The implantation methodology is also an important con-
sideration to minimise trauma to the existing IVD tissue [30,31].
We have previously reported the development of a synthetic
Laponite crosslinked pNIPAM-co-DMAc (L-pNIPAM-co-DMAc)
hydrogel delivery system which has the potential to deliver human
MSCs (hMSCs) via minimally invasive injection, using small bore
needles (26G) which decrease the chance of inducing damage to
the annulus fibrosus [23]. We have demonstrated in vitro that
hMSCs incorporated into L-pNIPAM-co-DMAc hydrogels and cul-
tured in 5% O2, differentiated into NP-like cells, without the use
of chondrogenic inducing medium or additional growth factors
[23]. The clinical success of this hydrogel is dependent on: integra-
tion with surrounding tissue; the capacity to restore mechanical
function; as well as supporting the viability and differentiation of
delivered MSCs.
In the present study, we investigated the efficacy of several IVD
repair strategies including: hMSCs alone, acellular L-pNIPAM-co-
DMAc hydrogel or hMSCs incorporated within L-pNIPAM-co-
DMAc hydrogel, injected into bovine NP tissue explants. This study
tested the hypothesis that the delivery of hMSCs within the L-
pNIPAM-co-DMAc hydrogel would aid scaffold integration, and
promote differentiation of MSCs towards the correct NP cell phe-
notype within native NP tissue. We additionally investigated the
mechanical function, defined in this study as disc apparent modu-
lus, strain under load, energy dissipation, and restoration of hydro-
gel injected bovine IVDs following collagenase digestion. Together
these investigations determine the capacity of this hydrogel to beused as both a cell delivery vehicle and as a mechanical support
scaffold in the treatment of IVD degeneration.2. Materials and methods
2.1. Nucleus pulposus tissue explant culture
Bovine tails from 9 months old to 18 months old cows were
obtained from the abattoir. Caudal IVDs were excised and NP tissue
was isolated. Cores of NP tissue (0.5 cm in diameter) were formed
and placed in a Perspex ring, in sterile 6 well culture plates, as
previously described [17]. Ten millilitres of DMEM media (Life
Technologies, Paisley UK) supplemented with 10% v/v heat inacti-
vated foetal calf serum (FCS) (Life Technologies, Paisley UK), 100U/
ml penicillin (Life Technologies Paisley UK), 100 lg/ml strepto-
mycin (Life Technologies Paisley UK), 250 ng/ml amphotericin
(Sigma, Poole UK), 2 mM glutamine (Life Technologies, Paisley
UK) and 10 lg/ml ascorbic acid (Sigma, Poole UK) (complete cell
culture media) was applied and tissue explants were maintained
in culture for 48 h prior to hMSC and hydrogel injection.
2.2. Hydrogel synthesis
An exfoliated suspension of Laponite clay nanoparticles (25–
30 nm diameter, <1 nm thickness) (BYK Additives Ltd, Cheshire
UK) was prepared by vigorous stirring of Laponite (0.1 g) in deio-
nised H20 (10 ml) (18 MX) for 24 h. N-isopropylacrylamide 99%
(NIPAM) (0.783 g) (Sigma, Poole UK), N,N0-dimethylacrylamide
(DMAc) (0.117 g) (Sigma, Gillingham UK) and 2-20-azobisisobutyro
nitrile (AIBN) (0.009 g) (Sigma, Poole UK) were added to the sus-
pension and stirred for 1 h. After passing the suspension through
a 5–8 mm pore filter paper, polymerisation was initiated by heating
to 80C and the reagents were allowed to react for 24 h. Following
24 h the hydrogel suspension was cooled to 38–39 C prior to cell
incorporation. Further cooling of the polymeric suspension to
37 C, i.e. below the lower critical solution temperature (LCST),
resulted in rapid gelation to a solidified hydrogel, as previously
described [23].
2.3. Mesenchymal stem cell source, expansion and transfer to nucleus
pulposus tissue explants
Commercial bone marrow derived human adult mesenchymal
stem cells (hMSCs) extracted from a 39 yr old donor (Lonza, Slough
UK) were cultured in complete DMEM media (Life Technologies,
Paisley UK). MSCs were expanded in monolayer culture to passage
7 to ensure sufficient cells were available. To allow cell tracking
following injection, the MSCs were labelled with a fluorescent
intracellular carboxyfluorescein N-hydroxysuccinimidyl ester
(CFSE) cell labelling kit, (Abcam, Cambridge, UK) according to man-
ufacturer’s instructions. Cell seeding solutions were prepared at a
density of 4  106 cells/ml in either complete DMEM media or liq-
uid hydrogel suspension (38–39 C) and then 50 ml injected into
the centre of NP tissue explants via 26 gauge needle injection (Bec-
ton Dickinson, Plymouth, UK). Fifty microliters of media or hydro-
gel suspension containing no cells was also injected via a 26 gauge
needle (Becton Dickinson, Plymouth, UK) into NP tissue explants.
This gave four experimental groups: media injected control (con-
trol), hMSC injected alone (hMSC), acellular L-pNIPAM-co-DMAc
hydrogel (acellular Hy) and hMSC incorporated within L-
pNIPAM-co-DMAc hydrogel (hMSC + Hy) injected NP tissue
explants. All NP tissue explants were cultured in complete DMEM
cell culture media via careful overlay of 10 ml of media per NP tis-
sue explant, incubated at 37 C, 5% CO2 and maintained in culture
for up to 6 weeks in an oxygen controlled glove box (Coy Lab
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Samples were removed after 48 h, 2, 4 and 6 weeks for analysis
of cell viability, scanning electron microscopy (SEM), histological
assessment of matrix deposition and NP cell phenotype analysis
using immunohistochemistry (IHC).
2.4. Cytospins
IHC was performed on MSCs taken from monolayer culture
prior to injection into NP tissue explants to serve as time zero con-
trols. Monolayer cells were trypsinised and cells fixed in 4% w/v
paraformaldehyde/PBS (Sigma, Poole UK) for 20 min, spun at
300 g for 5 min to form a cell pellet and resuspended in PBS to a
cell density of 300 cells per microlitre. One hundred microlitres
of cell suspension was then cytospun, formed via centrifugation
at 1000 rpm for 3 min (Shandon Cytospin 3, Thermo Scientific,
Loughborough UK). Slides were subsequently air-dried and stored
at 4 C until required for IHC analysis.
2.5. Processing of tissue explants and identification of the injection site
Triplicate NP tissue explants of each experimental group: con-
trol, hMSC alone, acellular Hy and hMSC + Hy, were fixed in 10%
w/v formalin (Leica Microsystems, Milton Keynes UK) overnight
prior to routine paraffin embedding. Tissue samples were serially
sectioned at 4 mm, perpendicular to the needle injection, and two
sections every 100 mm were mounted onto positively charged
slides (Leica Microsystems, Milton Keynes UK). Sections were air-
dried, dewaxed in Sub-X (Leica Microsystems, Milton Keynes
UK), dehydrated in industrial methylated spirit (IMS) (Fisher,
Loughborough UK), washed in deionised H2O and then stained
with either: routine haematoxylin and eosin (H&E) (Leica
Microsystems, Milton Keynes UK); or Hoechst nuclear fluorescent
staining (Sigma, Poole UK). Slides stained with H&E were
immersed in Mayers haematoxylin for 2 min, rinsed in water for
5 min, immersed in eosin for 2 min, dehydrated in IMS, cleared
in Sub-X and mounted in Pertex (Leica Microsystems, Milton Key-
nes UK). Slides stained with Hoechst were immersed in 5 pg/mL
Hoechst/PBS, incubated for 10 min, washed 3 times in PBS and
mounted in 90% v/v glycerol/PBS. Slides were then visualised using
light and fluorescent microscopy with an Olympus BX51 micro-
scope and images captured by digital camera and Capture Pro
OEM v8.0 software (Media Cybernetics, Buckinghamshire, UK) to
identify the injection site and distinguish native NP cells
(Hoechst+/CFSE-) and injected hMSCs (Hoechst+/CFSE+). Within
control NP explants, the injection site was identified where the
needle track could be seen histologically (within early time points)
or halfway through the entire depth of the NP tissue explant.
Where MSCs were injected alone injection site was determined
via the identification of CFSE positive cells. Where acellular L-
pNIPAM-co-DMAc or L-pNIPAM-co-DMAc with incorporated MSCs
had been injected, the injection site was determined by the histo-
logical identification of the hydrogel. Following identification of
the position of the injection site and the presence of CFSE positive
cells, serial sections in the area of the injection site were mounted
onto positively charged slides: for caspase 3 IHC to identify the
presence of apoptotic cells, histological assessment of matrix com-
ponents using Alcian blue and Masson trichrome as well as IHC for
aggrecan, chondroitin sulphate and collagen type II to assess phe-
notypic characteristics.
2.6. Structural and mechanical characterisation
2.6.1. Scanning electron microscopy (SEM)
Samples were removed from culture after 48 h and 6 weeks,
frozen at 80 C and subsequently freeze dried using a FD-1A-50freeze drier set to 53 C, 3.8  104 mbar overnight. The sample
was then fractured to expose the interior surface morphology
attached onto an aluminium stub and then using a Quorum Tech-
nology 150 Q TES system coated with gold (10mA sputter current
for 180 s with a 2.7 tooling factor) for imaging.
The fractured surfaces were examined using a FEI NOVA nano-
SEM 200 scanning electron microscope (SEM). Secondary electron
images were obtained using accelerating voltage 5KV at various
magnifications ranging from 1000x to 40,000x.
2.6.2. Hydration degree
To evaluate the hydration degree of NP tissue explants, samples
were extracted from culture in triplicate following 48 h, 2, 4 and
6 weeks and the wet weight (M0) of the NP tissue explants was
measured. Samples were then freeze dried using a FD-1A-50 freeze
drier set to 53 C, 3.8  104 mbar overnight to obtain the dry
weight (Mt). The hydration degrees of the NP tissue explants were
calculated using Eq. (1):
Hydration degree ¼ ðM0 MtÞ
M0
 100 ð1Þ2.6.3. Dynamic mechanical analysis
The mechanical properties of NP tissue explants were charac-
terised following 6 weeks in culture. Replicate samples were
removed from culture, blotted and their mechanical properties
characterised by DMA. Samples were trimmed using a 5 mm cir-
cumference circular biopsy punch from the centre of NP tissue
explants, all sample heights were measured and recorded using
digital callipers prior to measurement. Triplicate samples were
analysed using a PerkinElmer DMA8000 model under confined
compression mode at 25 C, applying a sinusoidal force with a
0.02 mm displacement at 2.5 Hz.
2.7. Histological evaluation of matrix components
Matrix deposition around the injection site of NP tissue
explants was investigated following 48 h, 2, 4 and 6 weeks in trip-
licate. Sections were dewaxed in Sub-X, dehydrated in IMS, washed
in deionised H2O and then stained using histological stains: 1% w/v
Alcian blue (pH 2.5) (Sigma Aldrich, Poole UK) in 3% v/v acetic acid
(Sigma Aldrich, Poole UK) for 5 min with 1% Neutral red w/v (Sigma
Aldrich, Poole UK) used as a counter stain for 2 min or Masson tri-
chrome (Bio-Optica, Miller & Miller (Chemicals) Ltd, Hainault UK)
according to the manufacturer’s instructions. Sections were dehy-
drated in IMS, cleared in Sub-X and mounted in Pertex (Leica
Microsystems, Milton Keynes UK). All slides were examined with
an Olympus BX51 microscope and images captured by digital cam-
era and Capture Pro OEM v8.0 software (Media Cybernetics, Buck-
inghamshire, UK). Histological sections were analysed, features
noted and images captured to document their histological
appearance.
2.8. Immunohistochemistry assessment of apoptosis and phenotypic
characteristics
Caspase 3 as a marker of apoptosis and NP matrix markers:
aggrecan, collagen type II and chondroitin sulphate were selected
for immunohistochemistry (IHC) to assess the viability and pheno-
typic characteristics of NP tissue explants and delivered hMSCs. IHC
was performed as previously described [32]. Briefly, 4 lm paraffin
sections were de-waxed, rehydrated and endogenous peroxidase-
blocked using hydrogen peroxide (Sigma, Aldrich Poole UK). After
washing in tris-buffered saline (TBS; 20 mM tris, 150 mM sodium
chloride, pH 7.5) sections were subjected to antigen retrieval meth-
ods (Table 1). Following TBS washing, nonspecific binding sites
Table 1
Target antibodies used for IHC, their optimal concentrations and antigen retrieval methods. Heat antigen retrieval consisted of 10-min microwave irradiation in 0.05 M tris buffer,
pH 9.5 pre-heated to 60 C. Enzyme antigen retrieval consisted of 30-min incubation in TBS; 20 mM tris, 150 mM sodium chloride, 46.8 mM calcium chloride dihydrate pH 7.5,
containing 0.01% w/v a-chymotrypsin from bovine pancreas at 37 C.
Target antibody Clonality Optimal dilution Antigen retrieval Secondary antibody Serum block
Caspase 3 Rabbit polyclonal 1:400 None Goat anti rabbit Goat
Aggrecan Mouse monoclonal 1:100 Heat Rabbit anti mouse Rabbit
Collagen type II Mouse monoclonal 1:200 Enzyme Rabbit anti mouse Rabbit
Chondroitin sulphate Mouse monoclonal 1:400 Enzyme Rabbit anti mouse Rabbit
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(Abcam, Cambridge, UK) (Table 1) in 1% w/v bovine serum albumin
in TBS. Sectionswere incubated overnight at 4 Cwith the appropri-
ate primary antibody (Table 1). Negative controls in which mouse
or rabbit IgGs (Abcam Cambridge UK) replaced the primary anti-
body at an equal protein concentration were used (Table 1). After
washing in TBS, sections were incubated in 1:500 biotinylated sec-
ondary antibody (Table 1). Disclosure of secondary antibody bind-
ing was by the HRP-streptavidin biotin complex (30 min
incubation) (Vector Laboratories, Peterborough, UK), TBS washing,
followed by application of 0.08% v/v hydrogen peroxide in
0.65 mg/ml 3,30-diaminobenzidine tetrahydrochloride (Sigma
Aldrich, Poole UK) in TBS (20 min incubation). Sections were coun-
terstained with Mayer’s haematoxylin, dehydrated in IMS, cleared
in Sub-X and mounted in Pertex. All slides were visualised using
an Olympus BX51 microscope and images captured by digital cam-
era and Capture Pro OEM v8.0 software (Media Cybernetics, Buck-
inghamshire, UK). Evaluation of caspase 3 IHC staining was
performed by counting immunopositive and immunonegative cells
for each section and immunopositive cells expressed as a percent-
age of the total count. Images were captured for IHC staining of
NP markers: aggrecan, collagen type II and chondroitin sulphate
to qualitatively analyse the injection site, native disc cells/injected
cells and surrounding matrix.
2.9. Mechanical characterisation of L-pNIPAM-co-DMAc hydrogel
injected whole bovine IVDs
2.9.1. IVD isolation and collagenase digestion
Bovine tails from 9 to 18 month old cows were obtained from
the abattoir, operating in concordance with animal welfare regula-
tions. Tails were stored at 20 C shortly post sacrifice and tested a
maximum of one month post storage. Tails were thawed at 5 C for
24 h prior to sample preparation. Discs were dissected whole from
tail sections between cd1-2 and cd4-5. Discs without parallel faces
or with visible signs of damage were discarded. The remaining
discs were allowed to equilibrate to room temperature for 12 h
before testing, between 2 and 4 discs were gained from each tail
section. Discs were stored in airtight sealed bags to prevent dehy-
dration during this time. Discs were randomly assigned to four test
groups (n = 10 per group): healthy; sham injected; collagenase
digested and collagenase digested following hydrogel injected.
Healthy discs were not experimentally manipulated following
excision, sham injected discs were stabbed with a 21-gauge needle
to assess the effect of needle insertion. Collagenase digested and
hydrogel injected discs were injected with 100–200 ml of a 2 mg/
mL collagenase solution (Sigma, Poole, UK) in distilled water
(injection was performed until either the internal pressure in the
disc prevented any further injection or a maximum of 200 ml had
been injected) and incubated for 2 h at 37 C.
2.9.2. Injection of L-pNIPAM-co-DMAc hydrogel in whole bovine IVDs
Following collagenase digestion, discs to be injected with
hydrogel were inspected morphologically to ensure collagenase
digestion had successfully induced void formation. Hydrogelinjected discs then received an injection of 50–200 mL of acellular
L-pNIPAM-co-DMAc hydrogel, with an incorporated green food
dye for visulisation. Hydrogel injected discs were left 30 min post
injection to allow the L-pNIPAM-co-DMAc hydrogel to stabilize
and mimic the operation time for the patient, prior to testing.
Injection protocol consisted of the syringe being depressed until
either the internal pressure in the disc prevented any further
intake or a maximum of 200 ml of L-pNIPAM-co-DMAc hydrogel
had been injected. All the needle tips were inserted into the centre
of the NP before injection of material. Visual inspection during
injection allowed needle position to be observed through the
deformation of surrounding material.
2.9.3. Mechanical loading of IVDs
Discs were loaded cyclically using a dynamic test rig incorporat-
ing a hydraulic piston controlled by Wavematrix 1.8 test software
and a Labtronic 8800 hydraulic controller (Instron. Mass, USA).
Discs were placed between two smooth parallel metal platens
without further constraint. Discs with non-parallel surfaces were
rejected prior to testing and no lateral movement was observed
during testing (indicating that disc surfaces were parallel and all
deflection was in the axial direction). Discs were subjected to a
sinusoidal load between 0.53 and 0.65 MPa at 2 Hz to simulate
walking based on known values from the literature [51–53]. Each
disc was ramped to a preload at the midpoint between the upper
and lower boundaries at a rate of 0.01 kN/s, immediately upon
reaching the preload, cyclic loading was applied for 100 s, repre-
sentative of a short period of activity typical of activities of daily
living (ADLs) in all but the most severely impaired persons.
Three measures of mechanical response were tracked by the
data acquisition tools connected to Wavematrix. Engineering stiff-
ness of each disc was measured as the change in force divided by
the change in displacement from minimum (Fmin = 0.53 MPa 
disc cross-sectional area) to maximum (Fmax = 0.65 MPa  disc
cross-sectional area) loading. Strain was measured as the
displacement between those points divided by the disc height at
minimum loading. Lastly the energy dissipated by discs during
each loading/unloading cycle was calculated from the hysteresis
in the load deflection data and converted to J/cycle.
2.10. Data processing and statistical analysis
All tests were performed at least in triplicate. Data was assessed
for normality using the Shapiro Wilks test and found to be non-
parametric and hence statistical comparisons were performed by
Kruskal-Wallis with a pairwise comparisons (Conover-Inman) post
hoc test performed with statistical significance accepted at
p  0.05. Pairwise comparisons were made as follows: between
all-time points and between the different experimental groups
for caspase 3 immunopositivity; between the different experimen-
tal groups for mechanical analysis; hMSC alone, Acellular Hy and
hMSC + Hy compared with media injected control NP explants for
hydration assessment at each given time point. Data was then pre-
sented on graphs; all replicates have been shown with median
value indicated to demonstrate clearly the spread of replicates.
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3.1. Identification of injected L-pNIPAM-co-DMAc hydrogel and
mesenchymal stem cells
No CFSE (green) positive cells were identified within media
injected controls or acellular hydrogel injected NP tissue explants
(Fig. 1). CFSE positive MSCs were identified where MSCs had been
injected alone, where they remained in clusters at the vicinity of
the injection site following 4 weeks in culture (Fig. 1). Some CFSE
positive cells appeared to have migrated away from the injection
site following 6 weeks, although many were still in close proximity
to each other (Fig. 1). Infiltrating native NP cells stained with
Hoechst were identified within the acellular L-pNIPAM-co-DMAc
following 4 and 6 weeks in culture (Fig. 1). CFSE positive MSCs
were identified within the L-pNIPAM-co-DMAc hydrogel through-
out the 6 week culture duration where they had been incorporated
prior to injection (Fig. 1). CFSE positive MSCs were also observed
within the native NP tissue surrounding the hydrogel region fol-
lowing 6 weeks in culture (Fig. 1).3.2. Caspase 3 cell viability
Low levels of apoptosis was observed in media injected control
NP explant tissue, with no significant difference in the number of
caspase 3 immunopositive cells throughout the 6 week culture
duration (Fig. 2a, b). Where acellular L-pNIPAM-co-DMAc hydrogel
had been injected no significant difference in the number of cas-
pase 3 immunopositive cells was observed between native NP cells
within the surrounding NP tissue compared with native NP cells
infiltrated within the hydrogel (Fig. 2a, b). Low levels of apoptosis
within MSCs injected alone, with no significant difference in the
number of immunopositive cells observed throughout the 6 week
culture duration (Fig. 2a, b). Where MSCs were incorporated within
L-pNIPAM-co-DMAc hydrogel prior to injection, no significant dif-
ference in the number of caspase 3 immunopositive cells was
observed between cells found within the surrounding native NP
tissue and cells found within the L-pNIPAM-co-DMAc hydrogel
itself (Fig. 2a, b). No significant difference in the number of capsase
3 immunopositive cells was observed between the different exper-
imental groups at any time point (Fig. 2a, b) (P > 0.05).3.3. Structural and mechanical characterisation
3.3.1. Scanning electron microscopy
The interior micro scale morphology of NP tissue explants was
examined using scanning electron microscopy (SEM) (Fig. 3).
Native NP cells were visualised embedded within a disorganised
fibrous collagen matrix, throughout the 6 week culture duration
in media injected control explants (Fig. 3). Where MSCs were
injected alone clustered cells could be seen following 48 h which
appeared to have migrated following 6 weeks in culture (Fig. 3).
Injected acellular L-pNIPAM-co-DMAc hydrogel displayed a com-
paratively uniform interconnecting porous network encapsulated
by the surrounding NP tissue following 6 weeks in culture. Where
MSCs were incorporated within the L-pNIPAM-co-DMAc hydrogel
prior to injection, cells could be seen within the centre of the
hydrogel region (Fig. 3); a distinction in the microscale morphol-
ogy of the interior hydrogel was still evident in comparison to
the native surrounding NP tissue following 6 weeks, however inte-
gration could be seen at the hydrogel/NP tissue interface with con-
necting NP tissue fibres penetrating within the outside edges of the
hydrogel region (Fig. 3).3.3.2. Dynamic mechanical analysis
MSC injected and hydrogel injected NP tissue explants dis-
played similar mechanical properties to media injected control
explants with no significant difference in the elastic modulus (G0)
loss modulus (G00) or tan delta (tand) for any of the experimental
groups following 6 weeks in culture (Fig. 4a, b, c).
3.3.3. Hydration assessment
The injection of MSCs alone did not significantly alter the
hydration degree of NP tissue explants following 48 h, 4 and
6 weeks in culture, although a significant increase (P = 0.0011) in
the hydration of hMSC injected alone NP tissue explants was
observed in comparison to media injected control explants follow-
ing 2 weeks in culture (Fig. 4d). Where acellular L-pNIPAM-co-
DMAc hydrogel was injected a significant increase (P = 0.0064) in
the hydration degree was observed in comparison to media
injected control explants following 6 weeks in culture (Fig. 4d).
Where hMSCs were incorporated into L-pNIPAM-co-DMAc hydro-
gel prior to injection a significant increase in the hydration degree
was observed in comparison to media injected control explants fol-
lowing 2 (P = 0.0015) and 6 (P = 0.0095) weeks in culture in com-
parison to control explants (Fig. 4d).
3.4. Histological evaluation of matrix components
Reduced matrix staining for both proteoglycans, and collagen
was observed throughout the 6 week culture period within media
injected control NP explants (Fig. 5). Where MSCs were injected
alone, blue staining for proteoglycans was present within and sur-
rounding the cell clusters, although the staining intensity was less
than that of the native surrounding NP tissue (Fig. 5). Areas of blue
staining for collagen were also observed within cell clusters where
MSCs had been injected alone, although the majority of cells pre-
sent within the clusters were negative (red) for collagen staining
(Fig. 5). Positive blue matrix staining for both proteoglycans and
collagen was observed within the acellular L-pNIPAM-co-DMAc
hydrogel which had been injected into NP explants, particularly fol-
lowing 4 and 6 weeks (Fig. 5). A distinct native NP tissue border,
with high intensity collagen staining, was observed surrounding
the acellular L-pNIPAM-co-DMAc hydrogel following 48 h, 2 and
4 weeks in culture (Fig. 5). Blue positive proteoglycan and collagen
producing cells were observed within the L-pNIPAM-co-DMAc
hydrogel where hMSCs had been incorporated prior to injection
throughout the 6 week culture duration (Fig. 3). Native NP tissue
directly adjacent to L-pNIPAM-co-DMAc hydrogel with
incorporated hMSCs, demonstrated strong intensity staining for
both proteoglycans and collagen (Fig. 5). A distinct NP tissue border,
with high intensity collagen staining, was present surrounding the
L-pNIPAM-co-DMAc hydrogel, where MSCs were incorporated, fol-
lowing 48 h and 2 weeks in culture, however this was subsequently
absent with integration of the surrounding NP tissue within the
hydrogel observed following 4 and 6 weeks in culture (Fig. 5).
3.5. Immunohistochemical evaluation of cell phenotype
Immunohistochemistry was used to assess the expression and
localisation of the NP matrix markers collagen type II, aggrecan
and chondroitin sulphate within MSCs, both in monolayer and fol-
lowing injection into NP tissue explants, as well as within native
NP cells within the explant tissue (Fig. 6). Collagen type II, aggrecan
and chondroitin sulphatewas expressed by all native NP cells found
with control, acellular L-pNIPAM-co-DMAC injected, hMSC only
injected and hMSC incorporated within L-pNIPAM-co-DMAc
injected NP tissue explants, throughout the 6 week culture duration
(Fig. 6). Immunopositive cells for collagen type II, aggrecan and
chondroitin sulphate were identified surrounding the acelllular L-
Fig. 1. Photomicrographs of haematoxylin & eosin stain, Hoechst staining and green fluorescent protein CFSE positive cells (shown inset for hMSC and hMSC + Hy NP tissue
explants) in the injection sites of bovine nucleus pulposus tissue following 48 h, 2, 4 and 6 weeks in culture. Magnified images of native NP cells, stained with Hoechst,
surrounding acellular hydrogel, shown inset to aid visualisation. White arrows on acellular Hy images indicate cells, black arrows on H&E images indicate hydrogel/tissue
interface, red arrows on H&E images for hMSC + Hy indicate cells within hydrogel. Media injected control tissue (Control), CFSE positive hMSC injected alone (Injected hMSC),
L-pNIPAM-co-DMAc hydrogel injected without cells (Acellular Hy) and hMSC incorporated into L-pNIPAM-co-DMAc hydrogel injected (hMSC + Hy). Scale bar = 50 lm or
100 lm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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Fig. 2. Immunohistochemical detection of caspase 3 to assess cell viability after 48 h, 2, 4 and 6 weeks in culture. Percentage immunopositivity was calculated (A).
Photomicrographs representative of caspase 3 immunopositivity in tissue explants at 48 h and 6 weeks post injection (B). Back arrows indicate positively stained cells and
white arrows indicate negatively stained cells. Scale bar = 100 lm.
Fig. 3. Scanning Electron Microscopy (SEM) of media injected control (Control), hMSC injected alone (hMSC), Acellular L-pNIPAM-co-DMAc hydrogel injected (Acellular Hy)
and hMSC incorporated within L-pNIPAM-co-DMAC hydrogel injected (hMSC + Hy) NP tissue explants following 48 h and 6 weeks in culture. Enlarged images of native NP
cells (control), hMSCs (hMSCs injected alone) and cells within hydrogel region (Acell 6 weeks, hMSC + Hy 48 h and 6 weeks) shown inset for visualisation. White arrows
indicate native NP cells within Control NP explants and presence of hMSCs within hMSC injected alone NP explants. Blue arrows indicate NP tissue/hydrogel interface,
demonstrating integration of hydrogel with surrounding NP tissue. Scale bar 50 mm.
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Fig. 4. Mechanical analysis of bovine explant NP tissue using dynamic mechanical analysis (A, B, C). (A) Elastic modulus (G0), (B) loss modulus (G00) and (C) Tan Delta (tand) at
2.5 Hz after 6 weeks in culture. (D) Calculated hydration degree of bovine explant tissue throughout 6 weeks in culture. Media injected control (con), hMSC injected alone
(hMSC), acellular L-pNIPAM-co-DMAc injected (Acell Hy) and hMSC incorporated into L-pNIPAM-co-DMAc injected (hMSC + Hy). (*) Indicates statistical significance
compared to controls at each timepoint (D) (*p =  0.05).
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ture, with some immunopositive native NP cells for collagen type
II, aggrecan and chondroitin sulphate observed within the acellular
L-pNIPAM-co-DMAc hydrogel following 6 weeks in culture (Fig. 6).
Monolayer MSCs extracted from culture prior to injection into NP
tissue explants showed no immunopositivity for aggrecan, with
low levels of immunopositivity for chondroitin sulphate (average
52% range 50–55%) and collagen type II (average 17% range 14–
20%) (Suppl Fig. 1). Immunopositive cellular and matrix staining
for collagen type II, aggrecan and chondroitin sulphatewas observed
within the vicinity of the cell clusters where hMSCs had been
injected alone, from 48 h to 6 weeks in culture (Fig. 6). Intense
matrix staining and positive cellular staining for collagen type II,
aggrecan and chondroitin sulphate was observed within the
L-pNIPAM-co-DMAc hydrogel where MSCs had been incorporated
prior to injection (Fig. 6). NP tissue with high intensitymatrix stain-
ing for collagen type II and chondroitin sulphate was present inte-
grating within the L-pNIPAM-co-DMAc hydrogel where MSCs had
been incorporated prior to injection, following 6 weeks in culture
(Fig. 6). All IgG control sections for collagen type II, aggrecan and
chondroitin sulphate showed no immunopositivity (suppl Fig. 1).
3.6. Mechanical characterisation of L-pNIPAM-co-DMAc hydrogel
injected whole bovine IVD
Whole bovine IVDs subjected to loading simulating a short
period of walking demonstrated a different mechanical responsedepending on the treatment regime of the disc. When differences
in disc size were accounted for and outliers excluded healthy
discs had 1.88 times higher stiffness (24.3–12.9 MPa) (Fig. 7A),
80% lower strain (0.54–2.7%) (Fig. 7B) and 2.8 times greater
energy dissipation (2.12–0.76 J/cycle) (Fig. 7C) compared to discs
that had undergone collagenase digestion, with P < 0.001 in each
case when outliers were accounted for (Fig. 7). Discs subjected
to collagenase digestion could be seen in 6 out of 10 discs to
display clear digestion of the IVD (Fig. 7) with alteration to
mechanical properties, however 4 discs which were injected with
collagenase failed to show evidence of digestion (no voids
visible) and thus were removed from the statistical analysis
and showed as red outliers (Fig. 7). Discs subjected to the same
collagenase treatment process following observation of clear
evidence of digestion morphologically were subsequently
injected with L-pNIPAM-co-DMAc hydrogel, these discs demon-
strated a complete recovery of disc stiffness, displaying only
non-significant (P > 0.05) differences from healthy disc stiffness
(24.3–26.4 MPa) (Fig. 7A) and strain values (0.54–0.5%) (Fig. 7B).
However there was no recovery of the discs ability to dissipate
energy (Fig.7C), with hydrogel injected discs dissipating less
energy than any other test group (0.40 J/cycle), significantly
(P < 0.001) lower than even collagenase digested discs (Fig. 7c).
Discs injected with hydrogel containing green dye could be
clearly identified macroscopically (Fig. 7D, E) and microscopically
were shown to fill the fissures formed via collagenase digestion
(Fig. 7F, G).
Fig. 5. Histological evaluation of bovine NP tissue explants using Alcian blue (AB) for proteoglycan deposition and Masson trichrome (MT) for collagen deposition after 48 h,
2, 4 and 6 weeks in culture. Media injected control tissue (control), hMSCs injected alone (hMSC), Acellular L-pNIPAM-co-DMAc injected (Acellular Hy) and hMSCs
incorporated within L-pNIPAM-co-DMAc hydrogel injected (hMSC + Hy). Black arrows indicate positively stained cells, red arrows indicate negatively stained cells and orange
arrows indicate hydrogel/NP tissue interface. Magnified images of representative cells shown inset for visualisation. Scale bar = 100 lm.
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Fig. 6. Immunohistochemical detection of NP matrix markers collagen type II, aggrecan and chondroitin sulphate in bovine NP tissue explants. Representative
photomicrographs after 48 h, and 6 weeks in culture. Black arrows demonstrate positively stained cells and green arrows demonstrate negatively stained cells. Enlarged
immunopositive cells shown inset for visualisation. Scale bar = 100 lm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web
version of this article.)
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4.1. Evaluation of biological performance to act as a cell delivery
vehicle
The clinical translation of hydrogels specifically developed for
the delivery of regenerative cells to the IVD is dependent on several
requirements: that they can be administered by a minimally inva-
sive procedure that delivers the required cell population without
detrimental effects to both the implanted cells and surrounding
tissues during delivery. That they are biocompatible and thus sup-
port the viability of delivered cells and native cell populations. The
hydrogel should facilitate cellular migration to aid in the integra-tion with surrounding tissue to prevent biomaterial extrusion.
Finally, the hydrogel can support and promote the differentiation
of delivered MSCs into biologically functional NP like cells in order
to repair and regenerate a matrix akin to native NP tissue.
4.1.1. Minimally invasive delivery of L-pNIPAM-co-DMAC hydrogel
In our previous in vitro studies we have demonstrated that
hMSC could be incorporated into liquid L-pNIPAM-co-DMAc
hydrogel, injected through a narrow 26-gauge needle before solid-
ification at 37 C with no detriment to cell viability [23,33]. Here,
acellular L-pNIPAM-co-DMAc hydrogel was injected through the
AF into collagenase digested bovine IVD via 26-gauge needle
injection. The hydrogel was maintained within the disc during
Fig. 7. Mechanical analysis of whole bovine IVDs that were healthy, stabbed with 21 G needle (sham), collagenase digested or collagenase digested followed by hydrogel
injection (hydrogel). Measured parameters include: (A) Young’s Modulus, (B) % Strain and (C) Energy Dissipation. Four discs (red) from the digested group demonstrated
young’s modulus and strain behaviour similar to sham injected suggesting collagenase injection had been insufficient and this was supported by the lack of morphological
evidence of collagenase digestion in these discs, thus were marked as outliers but energy dissipation was in line with other needle punctured discs. All replicates have been
shown with outliers marked in red to demonstrate clearly the spread of replicates. Median values indicated do not include outliers within digested group. (*) Indicates
significant differences between experimental groups (p = 0.05). (D) Representative macroscopic image of whole bovine IVD following collagenase digestion (average IVD
diameter 30 mm). (E) Representative macroscopic image following collagenase digestion and hydrogel injection, with a green food dye incorporated within the hydrogel to
aid visualisation. (F, G) Microscopic images stained with haematoxylin and eosin of whole IVD following collagenase digestion, hydrogel injection and mechanical loading.
Scale bar 1000 mm, 200 mm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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and macro fissures akin to those which could occur during IVD
degeneration. The selected needle diameter is an important design
consideration which is often dictated by the viscosity of the bioma-
terial being injected [34]. It is generally accepted that the needle
diameter should be as narrow as possible to avoid structural and
mechanical damage to surrounding tissues during injection. How-
ever decreasing the needle diameter for viscous biomaterials
increases injection pressures which can increase shear forces oncells reducing cell viability [34,35]. The low viscosity (0.97 MPas
at 54 C) [23] of the L-pNIPAM-co-DMAC liquid hydrogel, enabled
its injection with incorporated hMSCs into NP tissue explants with
no loss in viability. The minimally invasive route demonstrated
here offers significant advantage over previously developed hydro-
gels implanted into IVD tissue where nucleotomy was required to
create a void for the biomaterial to occupy [13–16,36], or large
diameter surgical implanting tools were used [37]. Moreover, the
synthetic route utilised, which exploits the thermal phase transi-
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ification at 37 C. This maintains the L-pNIPAM-co-DMAC hydrogel
and incorporated hMSCs within the injection site, whilst avoiding
the need for additional implantation devices to initiate in situ poly-
merisation such as those proposed for photopolymerised hydrogels
[15,25,34].
4.1.2. Biocompatibility of L-pNIPAM-co-DMAc hydrogel
The biocompatibility of delivered hMSCs is essential if the
repopulation of cells for the long term recovery and regeneration
of a functional NP matrix is to be a viable therapeutic option in
the treatment of IVD degeneration. In agreement with previous
studies [17,20,38–42], excellent viability across all time points
and all treatment regimes were observed. However, despite mim-
icking the hypoxic disc microenvironment, it should be noted that
the culture conditions used in this study do not completely reflect
that of the native IVD in terms of a mechanically loaded environ-
ment [43] and low nutrient supply [44]. Moreover, the degenerate
IVD is an extremely hostile biological environment with increased
production of matrix degrading enzymes [6] and pro-inflammatory
cytokines [8,9] which may affect viability in vivo. Future investiga-
tions to ascertain the survival of delivered MSCs within such con-
ditions is paramount to the clinical translation of this kind of
therapy. However the survival of MSCs incorporated within the
L-pNIPAM-co-DMAc hydrogel, is extremely promising since the
use of the hydrogel as a delivery system also provides the opportu-
nity to simultaneously deliver antagonists of catabolic mediators if
required.
4.1.3. Integration of L-pNIPAM-co-DMAc hydrogel
The infiltration of native NP cells, demonstrated in both acellu-
lar and hMSC incorporated within the L-pNIPAM-co-DMAc hydro-
gel injected into NP explants, is particularly important to aid in
scaffold integration with the surrounding NP tissue. Restoring opti-
mum mechanical function and prevent issues such as biomaterial
extrusion [14,45]. Integration of L-pNIPAM-co-DMAC hydrogel
with surrounding NP tissue was particularly evident in this study,
with deposited matrix penetrating within the hydrogel/tissue
interface shown histologically and using SEM. Despite initial
fibrous encapsulation observed surrounding the hydrogel follow-
ing 4 weeks in acellular L-pNIPAM-co-DMAc hydrogel injected
NP tissue explants, it is hypothesised that dynamic culture under
mechanical load would promote and accelerate the hydrogel tissue
integration, as dynamic compressive mechanical loading has been
shown to promote NP matrix biosynthesis [46], increase NP cell
metabolism [46,47] and promote proliferation and differentiation
of MSCs into NP-like cells [48,49].
4.1.4. Differentiation of MSCs following injection into NP tissue
explants
In agreement with previous studies [17], where MSCs were
injected alone into NP tissue explants, the cells were maintained
within clusters at the vicinity of the injection site for up to 4 weeks,
although migration was evident following 6 weeks in culture.
Migration and differentiation of these cells into NP like cells is
essential for efficacious NP matrix repair. Here MSCs injected alone
were shown to produce NP matrix components collagen type II,
aggrecan and chondroitin sulphate. The deposition of this matrix
was localised immunohistochemically to the clusters of MSCs visu-
alised, indicating that the MSCs themselves were responsible for
the matrix synthesis; this is in agreement with previous studies
[17,20,39]. Despite this, a major concern for the clinical translation
of stem cell therapy for the treatment of IVD degeneration is a lack
of control over the differentiation capacity of these cells following
injection into nucleus pulposus tissue [27]. In addition, the location
of these cells following injection is crucial since MSC leakage fol-lowed by undesirable bone formation has been reported previously
as a potential side effect of this therapeutic strategy [26]. The
incorporation of MSCs within the L-pNIPAM-co-DMAc hydrogel
during the liquid phase for delivery, is advantageous as it ensures
the interconnecting porous hydrogel network is able to assemble
around the cells. This ensures that in the initial weeks following
injection, the cells are maintained within the injection site and that
the microenvironment of the hydrogel itself will be the first
structural influence on the differentiation capacity of the MSCs.
This gives a greater potential control over the differentiation and
location of the delivered regenerative cells. We have
previously demonstrated in vitro that MSCs incorporated into
L-pNIPAM-co-DMAc hydrogel and cultured under hypoxic condi-
tions induces differentiation of MSCs into NP like cells without
the need for additional chondrogenic inducing medium or growth
factors [23]. Here, we have shown that cells incorporated into
L-pNIPAM-co-DMAc hydrogel and injected into NP explants were
shown to produce NP matrix components: collagen type II; aggre-
can and chondroitin sulphate. We are unable to ascertain whether
the matrix deposition itself is from the delivered MSCs or native NP
cells, it is most likely to be a combination of both since positive
cells and deposited matrix which compositionally reflects native
NP tissue, was observed both within the hydrogel itself and sur-
rounding the hydrogel/tissue interface. Thus the translation of
our previous in vitro results within an ex vivo NP tissue explant
model demonstrated here, offers significant promise for the effi-
cacy of this therapeutic strategy in the delivery of MSCs for the
repair and regeneration of the NP as a future treatment of IVD
degeneration. A short coming of the current study is that commer-
cial MSCs were utilised, thus future investigations should be con-
ducted to assess the differentiation of MSCs from a large cohort
of human patients to determine patient variability and age of
patients which can be utilised for such a therapy.
4.2. Evaluation of mechanical properties to act as a support scaffold
The NP is regarded as a viscoelastic material, exhibiting both
fluid and solid like behaviours [50]. It has been well documented
that the viscoelasticity of NP tissue changes with ageing and
degeneration, exhibiting a more ‘solid-like’ than ‘fluid-like’ beha-
viour, reflected by a decreased tand [51]. One of the hallmarks of
IVD degeneration is a reduction in the overall proteoglycan content
[7] resulting in reduced tissue hydration [4,52,53]. The injection of
a hydrogel biomaterial, defined as a 3D hydrated crosslinked poly-
meric network, has therefore been hypothesised as an appealing
strategy to restore NP tissue hydration and thus potentially regain
some of the viscoelastic NP material properties [54,55]. The
significant increase in hydration degree of NP tissue explants
following 6 weeks where acellular and hMSC incorporated
L-pNIPAM-co-DMAc hydrogel was injected, provides promising
evidence to suggest that the L-pNIPAM-co-DMAc hydrogel mate-
rial itself is compositionally advantageous to the overall NP tissue
hydration. The benefits of which would be even more apparent
within degenerate tissue. Despite the increased hydration degree
no significant difference in the G0, G00 or the tand were observed
regardless of whether hMSCs or L-pNIPAM-co-DMAc hydrogel
were injected. This is likely due to the fact that the NP tissue
explant controls used in this study were not experimentally
manipulated to be degenerate; thus the fact that there is no statis-
tical difference in the viscoelastic parameters assessed between
the different experimental groups, indicates that both hMSC and
L-pNIPAM-co-DMAc hydrogel injected NP tissue explants display
similar biomechanical properties to native NP tissue. A limitation
that should be considered however is that in this study the NP tis-
sue explants were statically cultured within a semi-constrained
Perspex ring culture system, therefore the biomechanical proper-
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tissue found within the body [49,56].
Loading of whole bovine collagenase digested IVDs injected
with L-pNIPAM-co-DMAc hydrogel, demonstrated a significant
recovery of structural properties, completely regaining pre-
digested levels of disc stiffness. The full recovery of disc mechani-
cal response following hydrogel injection, shown in this study, is a
highly promising result, providing supporting evidence that the
hydrogel could offer a significant and near immediate structural
benefit to degenerate IVDs.
Unfortunately modelling degeneration in the disc is problem-
atic, and whilst collagenase digestion targets the collagen matrix
within the disc the proteoglycan components would still be non-
digested. However as the collagen matrix forms the interconnect-
ing network which holds the proteoglycan proteins in place, it
was observed that the majority of collagenase digested discs gen-
erated large voids both macro and microscopically mimicking at
least in part morphological features of degeneration. A limitation
of the current study was that digestion of the discs using collage-
nase did not always induce digestion (4 out of 10 discs) and these
samples failed to show any mechanical response. Therefore when
performing the hydrogel injection following collagenase digestion,
discs were carefully examined to ensure voids were visible prior to
hydrogel insertion. Following loading, histological analysis
demonstrated collagenase digested voids were filled with hydro-
gel, in all discs investigated.
The reduced stiffness of collagenase digested discs and subse-
quent recovery following the introduction of the L-pNIPAM-co-
DMAc hydrogel system may initially seem counter intuitive. Dam-
age and degeneration of the NP expected to reduce ‘fluid-like’
behaviour of the disc in favour of stiffer, ‘solid-like’ behaviour
[4,51,53]. The collagenase digestion process resulted in the cre-
ation of voids or fissures within the NP, as evidenced by macro
and microscopic imaging of tissues, but minimal structural damage
to the AF. The result, in vitro, is a disc which maintains its original
height yet contains easily compressible voids, resulting in reduced
bulk stiffness. More significant breakdown of disc tissue or full or
partial excision of the disc nucleus, particularly when combined
with long term, continuous pressure on the IVD in vitro [57] is
liable to compress voids, reducing disc height and resulting in a
thin disc of mostly AF tissue, which is stiffer than that of the NP
[58]. This non-linear variation in disc stiffness with degeneration
grade has previously been observed in torsion, flexion and bending
[59,60]. When comparing stiffness of moderately degenerate discs
compressed in vitro to degenerate discs in vivo it may be more
accurate to look at the results in terms of potential to lose disc
height, an important biomarker of disc degeneration [23–27].
Interestingly, significantly lower energy dissipation was
observed in groups injected with the needle: sham injected; colla-
genase digested; and collagenase digestion followed by hydrogel
injection, compared with healthy whole bovine IVDs. In contrast
Michalek & Iatridis, (2012) observed no apparent difference in
pressurization testing following needle puncture of bovine motion
segments [61]. Interestingly however the study by Michalek &
Iatridis (2012) induced a 10 mm deep defect within the AF which
would not have led to puncture of the NP, unlike the current study
where needle puncture was performed to the centre of the disc and
thus into the NP region [61]. Furthermore the loading rate investi-
gated by Michalek & Iatridis, (2012) was considerably lower
(0.1 Hz) compared to the 2 Hz used in the present study [61]. In
the present study these dynamic parameters were selected to mi-
mic that of walking in the human spine to enable a functional
assessment of the treatment methods. The loss in energy dissipa-
tion seen in the current study following needle puncture through
the AF and into the NP together with the results of Carragee
et al., 2009, suggests that the needle puncture itself in healthy IVDsmay be the key initiator of discs losing tissue functionality, likely
due to a loss in the pressure of the IVD [62]. However, as the
degenerate human disc will already have a reduced energy dissipa-
tion capacity due to matrix degradation and presence of fissures
[51,63,64]. The delivery of the L-pNIPAM-co-DMAc hydrogel sys-
tem via needle injection, is not likely to initiate any further loss
in energy dissipation but will provide an immediate mechanical
and clinical benefit in terms of IVD stabilisation, to what is likely
to be, at the time of patient treatment, a mechanically dysfunc-
tional tissue.
The injection of acellular L-pNIPAM-co-DMAc hydrogel injec-
tion did not recover energy dissipation to pre-digested levels; how-
ever the energy dissipation functionality is reliant on the unique
pressurised environment of the intact IVD [65], therefore it is unli-
kely that the implantation of a biomaterial alone would provide
this biomechanical function immediately. It is hypothesised that
over time as the L-pNIPAM-co-DMAc hydrogel integrates with sur-
rounding NP tissue, whilst the delivered MSCs simultaneously
repair and regenerate a biologically functioning NP matrix to fill
in any potential fissures, that the pressurised environment and
energy dissipation function of the IVD will be restored.
The mechanical benefit of hydrogel injection within IVDs has
been previously reported, including the restoration of the load
transmission [36] and re-established disc height maintained over
0.5 million loading cycles within a bovine organ culture model
[15], however in both cases, nucleotomy was required for hydrogel
implantation and the incorporation and delivery of cells was not
investigated. Recently Balkovec et al., 2016 reported the restora-
tion of segmental kinematics to pre injury state in IVDs with disc
height loss, following hydrogel injection, within an ex vivo porcine
cervical spine model; however again nucleotomy was required to
inject the hydrogel, the incorporation and delivery of cells was
not investigated [13] and the immediate mechanical restoration
of the hydrogel was not maintained following cyclic loading [14].
The development of a biomaterial which offers the ability to
safely deliver and differentiate cells, without the use of additional
growth factors, as well as providing mechanical stabilisation, has
so far not been achieved. Here, we demonstrate that the L-
pNIPAM-co-DMAc hydrogel can be delivered by minimally inva-
sive injection into collagenase digested whole bovine IVDs. Where
it fills micro and macro fissures, is maintained within the disc dur-
ing loading and provides immediate mechanical stabilisation with
improved disc stiffness back to non-digested levels, without the
need for prior removal of the NP tissue. Future investigations are
required to assess the fatigue properties of the hydrogel following
prolonged cyclic loading. The promising results displayed here sug-
gest that the L-pNIPAM-co-DMAc hydrogel could provide a treat-
ment strategy which requires a less invasive surgical
intervention, in regards to removal of native tissue, which may
promote better tissue integration and tissue functionality. More-
over the ability to safely deliver and promote NP differentiation
of MSCs within the L-pNIPAM-co-DMAc hydrogel system also pro-
vides the opportunity to biologically repair the disc as well as pro-
viding mechanical stability.
4.3. Treatment design strategy tailored for stage of degeneration
Our improved understanding of the underlying pathogenesis of
IVD degeneration over recent years and the consequential morpho-
logical changes that occur should be conveyed in our treatment
design strategies [21,22]. It is possible that clinicians could be pre-
sented with a variety of treatment options, both cellular and acel-
lular, in order to deliver the most efficacious, safe and cost effective
treatment for the stage of degeneration [21]. Of course clinical
translation is reliant on the detection and diagnosis of patients
with early to mid-stages of IVD degeneration; however recent
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possibility [66]. Future investigations into the survival and differ-
entiation of MSCs within the hostile environment of a severely
degenerate IVD are crucial in determining the success of stem cell
intervention for these patients. Additionally hydrogel containment
and mechanical stability within severely degenerate IVDs, where
annular fissures, osteophytes and endplate fractures may be clini-
cally present, must also be investigated to assess whether hydro-
gels can offer clinical benefit for late stage IVD degeneration. The
results of these investigations, in combination with the design of
suitable biomaterials and diagnostic techniques will determine
the future possibility of personalized therapies for IVD
degeneration.
5. Conclusion
Here, we investigated the efficacy of a range of treatment
options: hMSCS injected alone, acellular L-pNIPAM-co-DMAc and
hMSCs incorporated within the L-pNIPAM-co-DMAc hydrogel,
injected into bovine NP tissue explants. Demonstrating that hMSCs
injected alone or incorporated within the L-pNIPAM-co-DMAc
hydrogel are able to differentiate and produce NP matrix
components, thus providing compelling evidence in support of cell
delivery for NP matrix repair. Additionally we have demonstrated
immediate mechanical stabilisation with the injection of acellular
L-pNIPAM-co-DMAc hydrogel into whole bovine IVDs, demonstrat-
ing a potential clinical benefit even in the absence of cells. The
delivery of the L-pNIPAM-co-DMAc hydrogel system via minimally
invasive 26 gauge needle injection and its ability to fill micro fis-
sures, without the removal of the existing NP tissue, provides the
opportunity to target symptomatic patients in early to mid-
stages of degeneration. The use of a combined cellular and
mechanical repair approach is particularly promising since it is
hypothesised that the L-pNIPAM-co-DMAc hydrogel, could restore
disc height, thus providing immediate pain relief, whilst delivery of
MSCs provides gradual regeneration.
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